Inhibition of intestinal cholesterol absorption by ezetimibe in humans

被引：0
|
作者：
Sudhop, T
Lutjohann, D
Kodal, A
Tribble, D
Shah, S
Perevozskaya, I
von Bergmann, K
机构：
[1] Univ Bonn, D-5300 Bonn, Germany
[2] Merck Res Labs, Rahway, NJ USA
来源：
CIRCULATION | 2002年 / 106卷 / 19期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
224
引用
收藏
页码：45 / 45
页数：1
相关论文
共 50 条
  • [1] Inhibition of intestinal cholesterol absorption by ezetimibe in humans
    Sudhop, T
    Lütjohann, D
    Kodal, A
    Igel, M
    Tribble, DL
    Shah, S
    Perevozskaya, I
    von Bergmann, K
    [J]. CIRCULATION, 2002, 106 (15) : 1943 - 1948
  • [2] Inhibition of intestinal cholesterol absorption and endogenous cholesterol synthesis by ezetimibe/simvastatin in humans
    Sudhop, T
    Lutjohann, D
    Reber, M
    Tribble, DL
    Gibbons, P
    Sapre, A
    von Bergmann, K
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 392A - 392A
  • [3] Inhibition of intestinal cholesterol absorption and endogenous cholesterol synthesis by ezetimibe/simvastatin in humans
    Lütjohann, D
    Sudhop, T
    Reber, M
    Tribble, DL
    Gibbons, P
    Sapre, A
    von Bergmann, K
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (09) : 713 - 713
  • [4] Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans
    Davidson, Michael H.
    Voogt, Jason
    Luchoomun, Jayraz
    Decaris, Julie
    Killion, Salena
    Boban, Drina
    Glass, Alexander
    Mohammad, Hussein
    Lu, Yun
    Villegas, Deona
    Neese, Richard
    Hellerstein, Marc
    Neff, David
    Musliner, Thomas
    Tomassini, Joanne E.
    Turner, Scott
    [J]. ATHEROSCLEROSIS, 2013, 230 (02) : 322 - 329
  • [5] INHIBITION OF INTESTINAL CHOLESTEROL ABSORPTION AND ENDOGENOUS CHOLESTEROL PRODUCTION BY EZETIMIBE/SIMVASTATIN IN MAN
    Luetjohann, D.
    Sapre, A.
    Sudhop, T.
    Taggart, W.
    Musliner, T.
    von Bergmann, K.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 189 - 189
  • [6] Inhibition of intestinal cholesterol absorption by ezetimibe is a novel therapeutic target for fatty liver
    Yamagishi, S
    Nakamura, K
    Matsui, T
    Sato, T
    Takeuchi, M
    [J]. MEDICAL HYPOTHESES, 2006, 66 (04) : 844 - 846
  • [7] CHOLESTEROL BALANCE IN THE PRESENCE OF INHIBITION OF INTESTINAL ABSORPTION AND ENDOGENOUS PRODUCTION BY EZETIMIBE AND/OR SIMVASTATIN IN MEN
    Taggart, W.
    Musliner, T.
    von Bergmann, K.
    Luetjohann, D.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [8] CHANGES IN THE INTESTINAL ABSORPTION OF PHYTOSTEROLS AND CHOLESTEROL BY EZETIMIBE AND/OR SIMVASTATIN IN MEN
    Taggart, W.
    Musliner, T.
    Reber, M.
    Sudhop, T.
    Sapre, A.
    von Bergmann, K.
    Luetjohann, D.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [9] Ezetimibe Improves Endothelial Function and Inhibits Rho-Kinase Activity Associated With Inhibition of Cholesterol Absorption in Humans
    Nochioka, Kotaro
    Tanaka, Shin-ichi
    Miura, Masanobu
    Zhulanqiqige, Do E.
    Fukumoto, Yoshihiro
    Shiba, Nobuyuki
    Shimokawa, Hiroaki
    [J]. CIRCULATION JOURNAL, 2012, 76 (08) : 2023 - 2030
  • [10] Intestinal cholesterol absorption inhibitor ezetimibe added to cholestyramine for sitosterolemia and xanthomatosis
    Salen, G
    Starc, T
    Sisk, CM
    Patel, SB
    [J]. GASTROENTEROLOGY, 2006, 130 (06) : 1853 - 1857
12345